{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:06:07Z","timestamp":1789761967117,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.idnow.2026.105313","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:02:43Z","timestamp":1782144163000},"page":"105313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world use of Dalbavancin for vascular graft and Endograft infections"],"prefix":"10.1016","volume":"56","author":[{"given":"C.","family":"Leanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ascione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carnevalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Faccenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Di Girolamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.idnow.2026.105313_bb0005","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1161\/CIR.0000000000000457","article-title":"Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association","volume":"134","author":"Wilson","year":"2016","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.idnow.2026.105313_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejvs.2019.10.016","article-title":"Editor\u2019s choice - European Society for Vascular Surgery (ESVS) 2020 clinical practice guidelines on the management of vascular graft and endograft infections","volume":"59","author":"Chakf\u00e9","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"10.1016\/j.idnow.2026.105313_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjsurg.2009.05.018","article-title":"Conservative treatment of vascular prosthetic graft infection is associated with high mortality","volume":"200","author":"Saleem","year":"2010","journal-title":"Am J Surg"},{"issue":"2","key":"10.1016\/j.idnow.2026.105313_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/diagnostics14020205","article-title":"High-grade infection after branched endovascular aortic repair in patient with recent COVID-19 hospitalization","volume":"14","author":"Mohseni","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.idnow.2026.105313_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s15010-020-01551-z","article-title":"Use of rifampicin and graft removal are associated with better outcomes in prosthetic vascular graft infection","volume":"49","author":"Coste","year":"2021","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idnow.2026.105313_bb0030","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06373-4","article-title":"Outpatient parenteral antimicrobial therapy (OPAT) for aortic vascular graft infection; a five-year retrospective evaluation","volume":"21","author":"Allen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idnow.2026.105313_bb0035","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae302","article-title":"The use of long-term antibiotics for suppression of bacterial infections","author":"Horne","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idnow.2026.105313_bb0045","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10096-024-04849-0","article-title":"Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature","volume":"43","author":"Lafon-Desmurs","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.idnow.2026.105313_bb0050","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.2147\/DDDT.S313756","article-title":"Real-world use of Dalbavancin in the era of empowerment of outpatient antimicrobial treatment: a careful appraisal beyond approved indications focusing on unmet clinical needs","volume":"15","author":"Gatti","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"10.1016\/j.idnow.2026.105313_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091882","article-title":"Clinical effectiveness and pharmacokinetics of Dalbavancin in treatment-experienced patients with skin, osteoarticular, or vascular infections","volume":"14","author":"Stroffolini","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.idnow.2026.105313_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1185602","article-title":"Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety","volume":"14","author":"Ruiz-Sancho","year":"2023","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.idnow.2026.105313_bb0065","article-title":"Long-term suppressive therapeutic-drug-monitoring-guided Dalbavancin therapy for cardiovascular prosthetic infections","volume":"12","author":"Gallerani","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.idnow.2026.105313_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s15010-019-01379-2","article-title":"Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection","volume":"48","author":"Ciccullo","year":"2020","journal-title":"Infection"},{"issue":"2","key":"10.1016\/j.idnow.2026.105313_bb0075","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejvs.2021.05.010","article-title":"Editor\u2019s choice - validation of the Management of Aortic Graft Infection Collaboration (MAGIC) criteria for the diagnosis of vascular graft\/Endograft infection: results from the prospective vascular graft cohort study","volume":"62","author":"Anagnostopoulos","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"10.1016\/j.idnow.2026.105313_bb0080","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semvascsurg.2023.03.006","article-title":"Contemporary multimodal approach to diagnosis and treatment of vascular graft and endograft infections","volume":"36","author":"Jepsen","year":"2023","journal-title":"Semin Vasc Surg"},{"issue":"6","key":"10.1016\/j.idnow.2026.105313_bb0085","doi-asserted-by":"crossref","first-page":"ofae271","DOI":"10.1093\/ofid\/ofae271","article-title":"Characteristics and outcome of vascular graft infections: a risk factor and survival analysis","volume":"11","author":"Stockschl\u00e4der","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idnow.2026.105313_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae271","article-title":"Characteristics and outcome of vascular graft infections: a risk factor and survival analysis","volume":"11","author":"Stockschl\u00e4der","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.idnow.2026.105313_bb0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/14787210.2023.2214727","article-title":"Direct or early discharge of acute bacterial skin and skin structure infection patients from the emergency department\/unit: place in therapy of dalbavancin","volume":"21","author":"Oliva","year":"2023","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"5","key":"10.1016\/j.idnow.2026.105313_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106960","article-title":"Expert opinion on dose regimen and therapeutic drug monitoring for long-term use of Dalbavancin: expert review panel","volume":"62","author":"Senneville","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.idnow.2026.105313_bb0105","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00259-018-4069-1","article-title":"The role of FDG PET\/CT in therapy control of aortic graft infection","volume":"45","author":"Husmann","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991926000709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:16:32Z","timestamp":1789758992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991926000709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666991926000709"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105313","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world use of Dalbavancin for vascular graft and Endograft infections","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2026.105313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105313"}}